185 related articles for article (PubMed ID: 35472140)
1. Effects of CB2 and TRPV1 Stimulation on Osteoclast Overactivity Induced by Iron in Pediatric Inflammatory Bowel Disease.
Tortora C; Di Paola A; Creoli M; Argenziano M; Martinelli M; Miele E; Rossi F; Strisciuglio C
Inflamm Bowel Dis; 2022 Aug; 28(8):1244-1253. PubMed ID: 35472140
[TBL] [Abstract][Full Text] [Related]
2. Alteration of osteoclast activity in childhood cancer survivors: Role of iron and of CB2/TRPV1 receptors.
Rossi F; Tortora C; Di Martino M; Di Paola A; Di Pinto D; Marrapodi MM; Argenziano M; Pota E
PLoS One; 2022; 17(7):e0271730. PubMed ID: 35862357
[TBL] [Abstract][Full Text] [Related]
3. Iron overload causes osteoporosis in thalassemia major patients through interaction with transient receptor potential vanilloid type 1 (TRPV1) channels.
Rossi F; Perrotta S; Bellini G; Luongo L; Tortora C; Siniscalco D; Francese M; Torella M; Nobili B; Di Marzo V; Maione S
Haematologica; 2014 Dec; 99(12):1876-84. PubMed ID: 25216685
[TBL] [Abstract][Full Text] [Related]
4. PKCβII-mediated cross-talk of TRPV1/CB2 modulates the glucocorticoid-induced osteoclast overactivity.
Bellini G; Torella M; Manzo I; Tortora C; Luongo L; Punzo F; Colacurci N; Nobili B; Maione S; Rossi F
Pharmacol Res; 2017 Jan; 115():267-274. PubMed ID: 27919827
[TBL] [Abstract][Full Text] [Related]
5. The Role of Mifamurtide in Chemotherapy-induced Osteoporosis of Children with Osteosarcoma.
Bellini G; Di Pinto D; Tortora C; Manzo I; Punzo F; Casale F; Rossi F
Curr Cancer Drug Targets; 2017; 17(7):650-656. PubMed ID: 27993113
[TBL] [Abstract][Full Text] [Related]
6. The genetic ablation or pharmacological inhibition of TRPV1 signalling is beneficial for the restoration of quiescent osteoclast activity in ovariectomized mice.
Rossi F; Bellini G; Torella M; Tortora C; Manzo I; Giordano C; Guida F; Luongo L; Papale F; Rosso F; Nobili B; Maione S
Br J Pharmacol; 2014 May; 171(10):2621-30. PubMed ID: 24308803
[TBL] [Abstract][Full Text] [Related]
7. The endovanilloid/endocannabinoid system in human osteoclasts: possible involvement in bone formation and resorption.
Rossi F; Siniscalco D; Luongo L; De Petrocellis L; Bellini G; Petrosino S; Torella M; Santoro C; Nobili B; Perrotta S; Di Marzo V; Maione S
Bone; 2009 Mar; 44(3):476-84. PubMed ID: 19059369
[TBL] [Abstract][Full Text] [Related]
8. CB(2) and TRPV(1) receptors oppositely modulate in vitro human osteoblast activity.
Rossi F; Bellini G; Tortora C; Bernardo ME; Luongo L; Conforti A; Starc N; Manzo I; Nobili B; Locatelli F; Maione S
Pharmacol Res; 2015 Sep; 99():194-201. PubMed ID: 26117426
[TBL] [Abstract][Full Text] [Related]
9. The Role of Cannabinoid Receptor Type 2 in the Bone Loss Associated With Pediatric Celiac Disease.
Tortora C; Punzo F; Argenziano M; Di Paola A; Tolone C; Strisciuglio C; Rossi F
J Pediatr Gastroenterol Nutr; 2020 Nov; 71(5):633-640. PubMed ID: 33093370
[TBL] [Abstract][Full Text] [Related]
10. The Endocannabinoid/Endovanilloid System in Bone: From Osteoporosis to Osteosarcoma.
Rossi F; Tortora C; Punzo F; Bellini G; Argenziano M; Di Paola A; Torella M; Perrotta S
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003519
[TBL] [Abstract][Full Text] [Related]
11. The endovanilloid/endocannabinoid system: a new potential target for osteoporosis therapy.
Rossi F; Bellini G; Luongo L; Torella M; Mancusi S; De Petrocellis L; Petrosino S; Siniscalco D; Orlando P; Scafuro M; Colacurci N; Perrotta S; Nobili B; Di Marzo V; Maione S;
Bone; 2011 May; 48(5):997-1007. PubMed ID: 21237298
[TBL] [Abstract][Full Text] [Related]
12. The calcium channel TRPV6 is a novel regulator of RANKL-induced osteoclastic differentiation and bone absorption activity through the IGF-PI3K-AKT pathway.
Ma J; Zhu L; Zhou Z; Song T; Yang L; Yan X; Chen A; Ye TW
Cell Prolif; 2021 Jan; 54(1):e12955. PubMed ID: 33159483
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of CB2 receptor in the intestinal biopsies of children with inflammatory bowel disease.
Strisciuglio C; Creoli M; Tortora C; Martinelli M; Miele E; Paino S; Luongo L; Rossi F
Pediatr Res; 2023 Feb; 93(3):520-525. PubMed ID: 35717484
[TBL] [Abstract][Full Text] [Related]
14. The TRPV1 ion channel antagonist capsazepine inhibits osteoclast and osteoblast differentiation in vitro and ovariectomy induced bone loss in vivo.
Idris AI; Landao-Bassonga E; Ralston SH
Bone; 2010 Apr; 46(4):1089-99. PubMed ID: 20096813
[TBL] [Abstract][Full Text] [Related]
15. Regulation of bone mass, osteoclast function, and ovariectomy-induced bone loss by the type 2 cannabinoid receptor.
Idris AI; Sophocleous A; Landao-Bassonga E; van't Hof RJ; Ralston SH
Endocrinology; 2008 Nov; 149(11):5619-26. PubMed ID: 18635663
[TBL] [Abstract][Full Text] [Related]
16. NRF2 is essential for iron-overload stimulated osteoclast differentiation through regulation of redox and iron homeostasis.
Zhang J; Zhang L; Yao G; Zhao H; Wu S
Cell Biol Toxicol; 2023 Dec; 39(6):3305-3321. PubMed ID: 37855941
[TBL] [Abstract][Full Text] [Related]
17. Immunolocalization of cannabinoid receptor type 1 and CB2 cannabinoid receptors, and transient receptor potential vanilloid channels in pterygium.
Assimakopoulou M; Pagoulatos D; Nterma P; Pharmakakis N
Mol Med Rep; 2017 Oct; 16(4):5285-5293. PubMed ID: 28849159
[TBL] [Abstract][Full Text] [Related]
18. Pentosan polysulfate regulates hepcidin 1-facilitated formation and function of osteoclast derived from canine bone marrow.
Wijekoon S; Sunaga T; Wang Y; Mwale C; Kim S; Okumura M
PLoS One; 2022; 17(3):e0265596. PubMed ID: 35299233
[TBL] [Abstract][Full Text] [Related]
19. The 17-β-oestradiol inhibits osteoclast activity by increasing the cannabinoid CB2 receptor expression.
Rossi F; Bellini G; Luongo L; Mancusi S; Torella M; Tortora C; Manzo I; Guida F; Nobili B; de Novellis V; Maione S
Pharmacol Res; 2013 Feb; 68(1):7-15. PubMed ID: 23142558
[TBL] [Abstract][Full Text] [Related]
20. Effects of emodin on inflammatory bowel disease-related osteoporosis.
Luo JS; Zhao X; Yang Y
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31934719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
